ACHV — Achieve Life Sciences Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$4.78
Market Cap$492M
Float87.2M
Shares Outstanding102.7M
P/E (Forward)35.34
Price/Sales (TTM)5.09
vs. Analyst Target+174.3% to analyst PT
Dividend RateNone
Analyst Target Price$13.11 (8 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$14.7M -$255,000 -$14.5M
2021 N/A -$32.9M -$250,000 -$32.8M
2022 N/A -$41.9M -$236,000 -$40.6M
2023 N/A -$29.8M -$228,000 -$26.7M
2024 N/A -$39.8M -$229,000 -$37.4M
2025 N/A -$54.6M -$228,000 -$54.7M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$12.7M
Sep 2025 N/A -$14.4M
Dec 2025 N/A -$14.7M
Mar 2026 N/A -$10.2M

Ownership & Float

Insider Ownership0.9%
Institutional Ownership61.0%
Short Float7.9%
% of All Funds Holding0.92%
Number of Funds Holding76

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$4.28Near-term / short-term trend
Weekly40-Week SMA$4.25Medium-term trend
Weekly80-Week SMA$3.64Cyclical trend (business cycle)
Weekly200-Week SMA$4.27Secular trend (multi-year)
Monthly10-Month SMA$4.19Near-term monthly trend
Monthly20-Month SMA$3.73Medium-term monthly trend
Monthly40-Month SMA$4.42Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$3.00 support 1.58x 0 months ago

Historical Earnings Reactions (121 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 1.14% 0.06% 50.41% 69.80% -11.32%
1 Day 0.06% 0.00% 45.45% 22.86% -34.91%
1 Week 0.26% 0.19% 51.24% 37.36% -38.68%
2 Weeks 2.74% 0.82% 50.00% 197.50% -71.30%
1 Month 4.93% 0.00% 48.33% 259.72% -82.61%

Next earnings: July 31, 2026 (63 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan16.7%64.5%31
Feb1.6%51.6%31
Mar-3.7%45.2%31
Apr7.7%45.2%31
May2.9%43.3%30
Jun-7.4%33.3%30
Jul6.6%60.0%30
Aug-4.4%36.7%30
Sep-10.5%40.0%30
Oct-7.2%30.0%30
Nov7.7%67.7%31
Dec-4.3%48.4%31

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.11% 43.7% 1448
Tuesday -0.04% 42.6% 1583
Wednesday 0.21% 43.7% 1580
Thursday -0.12% 40.7% 1548
Friday 0.22% 45.9% 1544

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 61.0%

Insider Transactions — Smart Summary

Total insider ownership: 0.9%

Founder-led management: Richard Stewart (Chief Executive Officer & Executive Director)

12-Month Insider Activity Summary

Total Filings6
Net Value-$697,589.93
Net Shares Change751,628
% of Float0.9%
C-Suite Filings5
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
KING THOMAS BRAXTON -$387,406.66 1 1 sell
Stewart Richard Alistair Chief Executive Officer -$378,142.92 1 1 sell
Oki Mark K Chief Financial Officer -$146,175.2 1 1 sell
JACOBS CINDY President and CMO -$76,532.33 1 1 sell
Xinos Jaime Chief Commercial Officer -$57,765.58 1 1 sell
Wan Jerry Principal Accounting Officer -$38,973.9 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-09-08 – 2025-09-22 6 6 -$1.1M 5 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-09-22 Stewart Richard Alistair Chief Executive Officer -$378,142.92 Transaction at $2.92, now +63.7%
2025-09-22 Oki Mark K Chief Financial Officer -$146,175.2 Transaction at $2.92, now +63.7%
2025-09-08 Xinos Jaime Chief Commercial Officer -$57,765.58 Transaction at $2.77, now +72.6%
2025-09-08 Wan Jerry Principal Accounting Officer -$38,973.9 Transaction at $2.77, now +72.6%
2025-09-08 JACOBS CINDY President and CMO -$76,532.33 Transaction at $2.77, now +72.6%
2025-09-08 KING THOMAS BRAXTON -$387,406.66 Transaction at $2.77, now +72.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Achieve Life Sciences Inc (ACHV) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ACHV on Trend Edge →